News - ThromboGenics

Filter

Current filters:

ThromboGenics

Popular Filters

19 to 26 of 26 results

FDA advisory panel backs approval of ThromboGenics' ocriplasmin for VMA

29-07-2012

Belgian biopharmaceutical firm ThromboGenics NV (Euronext Brussels: THR) says that the US Food and Drug…

AlconBiotechnologyNorth AmericaNovartisocriplasminOphthalmicsRegulationThromboGenics

News briefs: Priority review for ocriplasmin; Zonegran monotherapy in EU

03-07-2012

Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR) says that the US Food and Drug Administration…

EisaiEuropeNeurologicalNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenicsZonegran

Roche returns rights to TB-403 to ThromboGenics and BioInvent, who abandon TB-402 development

05-06-2012

Belgium-based biopharma company ThromboGenics NV (Euronext Brussels: THR) and co-development partner…

BayerBioInventBiotechnologyLicensingOncologyOphthalmicsPharmaceuticalRocheTB-402TB-403ThromboGenicsXarelto

ThromboGenics re-files ocriplasmin BLA and Inspiration submits IB 1001 to FDA

17-04-2012

Belgian biopharma company ThromboGenics NV (Euronext Brussels: THR) said this morning that it has resubmitted…

BiotechnologyInspiration BiopharmaceuticalsIpsenNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenics

Novartis unit buys rights to ThromboGenics eye drug

16-03-2012

Belgian biopharma company ThromboGenics (Euronext Brussels: THR) revealed this morning that it has entered…

AlconBiotechnologyLicensingNovartisocriplasminOphthalmicsPharmaceuticalThromboGenics

ThromboGenics confident as it plans for ocriplasmin launch

12-03-2012

Belgian biopharma firm ThromboGenics (Euronext Brussels: THR) says that, over the past 12 months, it…

BiotechnologyFinancialocriplasminOphthalmicsRegulationResearchThromboGenics

Positive new Ph III data on ThromboGenics’ ocriplasmin

22-08-2011

Belgian ophthalmic drug developer ThromboGenics (Euronext Brussels: THR) has presented strong new data,…

ocriplasminOphthalmicsPharmaceuticalResearchThromboGenics

19 to 26 of 26 results

Company Spotlight

Fibrotech

Fibrotech

Back to top